Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Alim-Louis Benabid Honored by U.S. Research Institute

Published: Friday, October 11, 2013
Last Updated: Friday, October 11, 2013
Bookmark and Share
Benabid has received the Jay Van Andel Award for Outstanding Achievement in Parkinson’s Disease Research.

CEA-Leti has announced that Prof. Alim-Louis Benabid, chairman of CLINATEC, has been honored by a second major U.S. Parkinson’s disease (PD) organization for his work in treating PD.

Benabid received the Jay Van Andel Award for Outstanding Achievement in Parkinson’s Disease Research at Van Andel Institute’s Grand Challenges in Parkinson’s Disease Symposium in September.

The award recognizes his invention of deep brain stimulation (DBS), a highly specialized method used to treat specific kinds of neurological diseases, including Parkinson’s disease.

“Dr. Benabid has made an incredible contribution to the treatment of Parkinson's disease by developing deep brain stimulation,” said Patrik Brundin, director of the Van Andel Institute’s Center for Neurodegenerative Science.

Brundin continued, “Today over 140,000 advanced Parkinson’s patients have undergone DBS treatment, which essentially changes the ‘electric connections’ in the brain, and they are able to move remarkably much better thanks to Dr. Benabid's invention.”

Benabid, who has received many honors during his career, was awarded the 2013 Robert H. Pritzker Prize for Leadership in Parkinson’s Research from the Michael J. Fox Foundation earlier this year.

“The Van Andel Institute’s research program has a powerful impact on biomedical research in cancer and Parkinson’s disease, with an emphasis on translating scientific research results into clinical applications,” Benabid said. “I am honored to receive this award, and I’m proud to highlight the CLINATEC team’s ongoing work on infrared brain stimulation to improve treatment of PD, and perhaps severe depression, Alzheimer’s disease, Tourette’s syndrome and other neurological conditions.”

Benabid helped found CLINATEC, the multidisciplinary biomedical research center created by Leti, Grenoble University Hospital, INSERM and Joseph Fourier University in 2009.

The center allows medical practitioners, researchers, biologists, and technologists to collaborate on the frontier of health care and micro- and nanoelectronics.

Using a unique biomedical and surgery platform, CLINATEC’s main objective is to accelerate and make safer the translation of technological innovation for treating patients.

Benabid has centered his scientific activity on the approach of neurosurgical pathologies, particularly brain tumors and movement disorders.

From 1989 to 2007, he was head of the Neurosurgery Department at the University Hospital of Grenoble. He currently is a professor emeritus of biophysics at Joseph Fourier University.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Turning up the Tap on Microbes Leads to Better Protein Patenting
Mining millions of proteins could become faster and easier with a new technique that may also transform the enzyme-catalyst industry, according to University of California, Davis, researchers.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Novel Proteins Linked to Huntington's Disease
University of Florida Health researchers have made a new discovery about Huntington's disease, showing that the gene that causes the fatal disorder makes an unexpected "cocktail" of mutant proteins that accumulate in the brain.
Enzyme Critical to Maintaining Telomere Length Discovered
New method expected to speed understanding of short telomere diseases and cancer.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos